Iterum Therapeutics plc (ITRM)

NASDAQ: ITRM · Real-Time Price · USD

1.170

-0.060 (-4.88%)

At close: Apr 1, 2025, 4:00 PM

1.200

+0.030 (2.54%)

After-hours: Apr 1, 2025, 4:57 PM EDT

Iterum Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2016
Cost of Revenue	0.25	-	-	-	-	Upgrade
Gross Profit	-0.25	-	-	-	-	Upgrade
Selling, General & Admin	7.98	7.48	12.77	13.83	11.05	Upgrade
Research & Development	10.46	39.99	17.62	10.71	21.07	Upgrade
Operating Expenses	18.44	47.47	30.38	24.54	32.13	Upgrade
Operating Income	-18.7	-47.47	-30.38	-24.54	-32.13	Upgrade
Interest Expense	-2.52	-1.43	-2.36	-4.53	-12.3	Upgrade
Other Non Operating Income (Expenses)	-3.32	11.14	-11.39	-61.79	-7.18	Upgrade
EBT Excluding Unusual Items	-24.53	-37.76	-44.13	-90.86	-51.6	Upgrade
Other Unusual Items	-	-	-	-	0.34	Upgrade
Pretax Income	-24.53	-37.76	-44.13	-90.86	-51.26	Upgrade
Income Tax Expense	0.24	0.61	0.3	0.71	0.74	Upgrade
Net Income	-24.77	-38.37	-44.43	-91.56	-52.01	Upgrade
Net Income to Common	-24.77	-38.37	-44.43	-91.56	-52.01	Upgrade
Shares Outstanding (Basic)	20	13	12	11	2	Upgrade
Shares Outstanding (Diluted)	20	13	12	11	2	Upgrade
Shares Change (YoY)	51.97%	5.93%	12.35%	580.42%	65.38%	Upgrade
EPS (Basic)	-1.26	-2.96	-3.63	-8.41	-32.49	Upgrade
EPS (Diluted)	-1.26	-2.96	-3.63	-8.41	-32.49	Upgrade
Free Cash Flow	-26.77	-39.34	-18.54	-15.9	-54.54	Upgrade
Free Cash Flow Per Share	-1.36	-3.04	-1.51	-1.46	-34.07	Upgrade
EBITDA	-18.41	-45.72	-28.58	-22.43	-31.97	Upgrade
D&A For EBITDA	0.28	1.75	1.8	2.1	0.16	Upgrade
EBIT	-18.7	-47.47	-30.38	-24.54	-32.13	Upgrade

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q